7 July 2023 in Nanoscale Advances
Gene therapy is a promising approach for the treatment of many diseases. However, the effective delivery of the cargo without degradation in vivo is one of the major hurdles. With the advent of lipid nanoparticles (LNPs) and cell-derived nanovesicles (CDNs), gene delivery holds a very promising future. The targeting of these nanosystems is a prerequisite for effective transfection with minimal side-effects. In this review, we highlight the emerging strategies utilized for the effective targeting of LNPs and CDNs, and we summarize the preparation methodologies for LNPs and CDNs. We have also highlighted the non-ligand targeting of LNPs toward certain organs based on their composition. It is highly expected that continuing the developments in the targeting approaches of LNPs and CDNs for the delivery system will further promote them in clinical translation.
24 December 2024 in Advanced Materials
22 August 2025 in Advanced Functional Materials
Tissue expansion is traditionally achieved by injecting saline into an implanted silicone balloon via external tubing, which causes patient discomfort. Hydrogels eliminate the need for tubing due to their self‐swelling properties, but they fail to prevent suture wound dehiscence due to immediate swelling after implantation. Here, the concept of “extended swelling” in an interpenetrating hydrogel network is introduced to avoid dehiscence. The hydrogel consists of enzymatically degradable hyaluronic acid (HA) networks and non‐degradable polyacrylic acid (PAAc) networks. The gel remains structurally intact until suture wound healing after implantation by the constraint of the HA networks on the PAAc networks. Upon hyaluronidase (HYAL) injection, the HA networks degrade, initiating the extended swelling after which enzymatic degradation controls its onset and rate. Furthermore, the generalized ideal elastomeric gel model is employed to understand the extended swelling process. The model predicts the maximum extended equilibrium swelling ratio in vivo, confirming the hydrogel's ability to generate sufficient pressure while preventing overexpansion beyond the tissue rupture threshold. The theoretical framework aligns with experimental observations, demonstrating that the tissue expansion is induced by yes1‐associated protein (YAP1)‐mediated epidermal proliferation. This approach establishes its potential as a next‐generation tissue expander for clinical applications.
3 June 2026 in Nature Materials
17 July 2026 in Advanced Functional Materials
Memristors emulate the synaptic plasticity of the human brain by exhibiting conductance modulation dependent on prior stimuli, thereby enabling simultaneous information processing and storage. Ionic memristors, which utilize the migration of biological ions (e.g., K + , Cl − ), exhibit history‐dependent synaptic plasticity and offer a more biocompatible approach than conventional solid‐state electronic memristors. However, existing ionic memristors typically employ rigid substrates and biologically incompatible materials, which limit their potential for use in implantable devices. Here, we report a fully biocompatible natural polymer‐based ionic memristor, comprising a hyaluronic acid hydrogel, a chitosan hydrogel, and a polydimethylsiloxane (PDMS) substrate. Hyaluronic acid and chitosan are biodegradable natural polymers widely used in biomedical applications, while PDMS is a biocompatible elastomer demonstrating safety. Furthermore, our memristor operates as a dynamic memristor capable of performing reservoir computing. The reservoir computing implemented via our memristor achieved a prediction accuracy of 98.94%, while reducing the training time by 36.8% compared to systems that do not incorporate the memristors. Notably, the device maintained its computational performance post‐implantation and demonstrated excellent biocompatibility in both in vitro and in vivo evaluations. Collectively, these results highlight the potential of our approach as an implantable platform for bio‐integrated computing and next‐generation biomedical engineering.